Relaxin: A possible future preventive therapy for cardiovascular disease in postmenopausal women and men?

Climacteric

Volumn 4, Issue 2, 2001, Pages 137-143

  Bigazzi, M ^a   Bani, D ^b   Sacchi, T Bani ^b  

^a Prosperius Institute   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Cardiovascular disease; Postmenopausal women; Relaxion

Indexed keywords

RELAXIN;

CARDIOVASCULAR DISEASE; DRUG EFFECT; DRUG RESEARCH; FEMALE; HEART INFARCTION; HORMONE ACTION; HUMAN; MALE; POSTMENOPAUSE; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW;

EID: 0034955647     PISSN: 13697137     EISSN: None     Source Type: Journal    
DOI: 10.1080/cmt.4.2.137.143     Document Type: Review

References (34)

1. Cardiovascular disease in women: A statement for the health care professionals from the American Heart Association
2. Cardiovascular health and disease in women
3. Trends in heart disease deaths in Olmsted County, Minnesota, 1979-1994
4. Trends in the incidence of coronary heart disease and changes in diet and lifestyle in women
5. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease
6. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
7. Effects of estrogen replacement on the progression of coronary-artery atherosclerosis
8. Coagulation effects of oral contraception
9. Radioimmunoassay of relaxin in pregnancy with an analogue of human relaxin
10. Relaxin in the peri-implantation period
11. Plasma immunoreactive relaxin levels in pregnant and non-pregnant women
12. Experimental relaxation of the pubic ligament of the guinea pig
13. Relaxin as a new hormone
14. Relaxin, a pleiotropic hormone
15. Relaxin favors the development of Th1-like T cells
16. Relaxin is a potent renal vasodilator in conscious rats
17. Central actions of relaxin. Fact or fiction?
18. Relaxin causes changes of the liver. In vivo studies in rats
19. A simple biological assay for relaxin measurement
20. The local administration of relaxin induces changes in the microcirculation of the rat mesocaecum
21. Effects of relaxin on the microvasculature of mouse mammary gland
22. Relaxin: A mammotropic hormone promoting growth and differentiation of the pigeon crop sac mucosa
23. Effects of relaxin on the endometrial stroma. Studies in mice
24. Relaxin-induced increased coronary flow through stimulation of nitric oxide production
25. Relaxin activates the L-arginine-nitric oxide pathway in vascular smooth muscle cells in culture
26. Relaxin and the cardiocirculatory system
27. Relaxin reduces the number of circulating platelets and depresses platelet release from megakaryocytes: Studies in rats
28. Relaxin depresses platelet aggregation. In vitro studies on isolated human and rabbit platelets
29. Relaxin counteracts myocardial damage induced by ischemia-reperfusion in isolated guinea pig hearts: Evidence for an involvement of nitric oxide
30. Relaxin protects against myocardial injury caused by ischemia and reperfusion in rat heart
31. Chronic decrease of blood pressure by rat relaxin in spontaneously hypertensive rats
32. Recombinant human relaxin in the treatment of scleroderma. A randomized, double-blind, placebo-controlled trial
33. An overview of clinical studies with recombinant human relaxin in systemic sclerosis
34. A new approach to the management of obliterative peripheral arterial disease